The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity Statement of Significance Current NK cell engagers (NKCE) show limited clinical efficacy. We developed a novel tetravalent NKCE platform incorporating a re

Antibody Therapeutics(IF=4.5, Oxford University Press)
🚀🚀The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity
academic.oup.com/abt/article/...
#NKengager #IL15 #Antibody